Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

about

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

Item

http://www.wikidata.org/entity/Q49586531

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

@en

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

@nl

type

Item

label

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

@en

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

@nl

prefLabel

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

@en

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

@nl

P1476

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

@en

P2093

Addolorata Corrado

http://www.w3.org/2001/XMLSchema#string

Francesco Paolo Cantatore

http://www.w3.org/2001/XMLSchema#string

Nicola Maruotti

http://www.w3.org/2001/XMLSchema#string

P2860

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)

Mechanisms of angiogenesis

Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy.

Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model.

The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis.

Reduction of Serum ADAM17 Level Accompanied with Decreased Cytokines after Abatacept Therapy in Patients with Rheumatoid Arthritis

P304

123-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/BTT.S143674

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Domenico Ribatti

P577

2017-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29276377

http://www.w3.org/2001/XMLSchema#string

P921

biotechnology

P932

5733924

http://www.w3.org/2001/XMLSchema#string